| 000116 (2015) |
N. Hermann [Autriche] | [Effectiveness of Live Attenuated Influenza Vaccines and Trivalent Inactivated Influenza Vaccines against confirmed Influenza In Children and Adolescents in Saxony-Anhalt, 2012/13]. |
| 000021 (2019) |
Micha Loebermann [Allemagne] ; Carlos Fritzsche [Allemagne] ; Hilte Geerdes-Fenge [Allemagne] ; Esther Heijnen [Pays-Bas] ; Daniel Kirby [États-Unis] ; Emil C. Reisinger [Allemagne] | A phase III, open-label, single-arm, study to evaluate the safety and immunogenicity of a trivalent, surface antigen inactivated subunit influenza virus vaccine produced in mammalian cell culture (Optaflu®) in healthy adults. |
| 000134 (2015) |
Carina Helmeke [Allemagne] ; Lutz Gr Fe [Allemagne] ; Hanns-Martin Irmscher [Allemagne] ; Constanze Gottschalk [Allemagne] ; Ioannis Karagiannis [Suède] ; Hanna Oppermann [Allemagne] | Effectiveness of the 2012/13 trivalent live and inactivated influenza vaccines in children and adolescents in Saxony-Anhalt, Germany: a test-negative case-control study. |
| 000092 (2016) |
Jakob P. Cramer [Allemagne] ; Katrin Dubischar [Autriche] ; Susanne Eder [Autriche] ; Gerd D. Burchard [Allemagne] ; Tomas Jelinek [Allemagne] ; Bernd Jilma [Autriche] ; Herwig Kollaritsch [Autriche] ; Emil Reisinger [Allemagne] ; Kerstin Westritschnig [Autriche] | Immunogenicity and safety of the inactivated Japanese encephalitis vaccine IXIARO® in elderly subjects: Open-label, uncontrolled, multi-center, phase 4 study. |
| 000205 (2013) |
Ulrich Zimmermann [Allemagne] ; Gaëtan Gavazzi ; Patrick Richard ; Cécile Eymin ; Benoît Soubeyrand ; Martine Baudin | Immunogenicity and safety of a booster dose of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine (Tdap-IPV; Repevax) administered concomitantly versus non-concomitantly with an influenza vaccine (Vaxigrip) to adults aged ≥60 years: an open-label, randomised trial. |
| 000126 (2015) |
Oliver Damm [Allemagne] ; Martin Eichner ; Markus Andreas Rose ; Markus Knuf ; Peter Wutzler ; Johannes Günter Liese ; Hagen Krüger ; Wolfgang Greiner | Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany. |
| 000157 (2014) |
Markus A. Rose ; Oliver Damm ; Wolfgang Greiner ; Markus Knuf ; Peter Wutzler ; Johannes G. Liese ; Hagen Krüger ; Ulrich Wahn ; Tom Schaberg ; Markus Schwehm ; Thomas F. Kochmann ; Martin Eichner [Allemagne] | The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study. |
| 000210 (2013) |
H. Englund [Allemagne] ; H. Campe ; W. Hautmann | Effectiveness of trivalent and monovalent influenza vaccines against laboratory-confirmed influenza infection in persons with medically attended influenza-like illness in Bavaria, Germany, 2010/2011 season. |
| 000215 (2013) |
G. Falkenhorst [Allemagne] ; T. Harder ; C. Remschmidt ; M. Terhardt ; F. Zepp ; T. Ledig ; S. Wicker ; B. Keller-Stanislawski ; T. Mertens | Background paper to the recommendation for the preferential use of live-attenuated influenza vaccine in children aged 2-6 years in Germany. |
| 000601 (1964) |
G. Starke ; I. Siebelist ; E. Hiller | [INVESTIGATIONS ON THE PROBLEM OF THE DETECTION OF LIVE INFLUENZA VACCINES. I. RESULTS OF A TEST OF LIVE A2-INFLUENZA-VACCINES IN A CONTROLLED EXPERIMENT WITH VOLUNTEERS]. |
| 000009 (2019) |
Ralf Wagner [Allemagne] ; Eberhard Hildt [Allemagne] | [Composition and mode of action of adjuvants in licensed viral vaccines]. |
| 000036 (2018) |
Evelyne Kretzschmar [Allemagne] ; Heide Muckenfuss [Allemagne] ; Michael Pfleiderer [Allemagne] | Official batch control of influenza vaccines: Is it still useful? |
| 000062 (2017) |
Seong-Su Yuk [Corée du Sud] ; T O Erdene-Ochir [Corée du Sud] ; Jung-Hoon Kwon [Corée du Sud] ; Jin-Yong Noh [Corée du Sud] ; Woo-Tack Hong [Corée du Sud] ; Jei-Hyun Jeong [Corée du Sud] ; Sol Jeong [Corée du Sud] ; Gyeong-Bin Gwon [Corée du Sud] ; Jong-Il Shin [Corée du Sud] ; Jung-Hyang Sur [Corée du Sud] ; Chang-Seon Song [Corée du Sud] | Efficacy of clade 2.3.2 H5 commercial vaccines in protecting chickens from clade 2.3.4.4 H5N8 highly pathogenic avian influenza infection. |
| 000084 (2016) |
Birgitta Weltermann [Allemagne] ; Anna Herwig [Allemagne] ; Dorothea Dehnen [Allemagne] ; Kerstin Herzer [Allemagne] | Vaccination Status of Pneumococcal and Other Vaccines in 444 Liver Transplant Patients Compared to a Representative Population Sample. |
| 000098 (2016) |
Christiaan Dolk [Pays-Bas] ; Martin Eichner [Allemagne] ; Robert Welte [Allemagne] ; Anastassia Anastassopoulou [Allemagne] ; Laure-Anne Van Bellinghen [Belgique] ; Barbara Poulsen Nautrup [Allemagne] ; Ilse Van Vlaenderen [Belgique] ; Ruprecht Schmidt-Ott [Allemagne, Belgique] ; Markus Schwehm [Allemagne] ; Maarten Postma [Pays-Bas] | Cost-Utility of Quadrivalent Versus Trivalent Influenza Vaccine in Germany, Using an Individual-Based Dynamic Transmission Model. |
| 000110 (2015) |
Peter Wutzler [Allemagne] ; Brigitte Dietz ; Roland Hardt ; Lutz Hoins ; Markus Knuf ; Klaus Wahle | [Quadrivalent influenza vaccines]. |
| 000154 (2014) |
J. Barth ; T. Hammerschmidt [Allemagne] ; J. Vollmar [Allemagne] ; M. Bierbaum ; O. Schöffski | [Mechanics and effects of European reference pricing for vaccines in Germany according to §130a Abs. 2 SGB V: an analysis using the example of influenza vaccines]. |
| 000195 (2013) |
S. Grund [Allemagne] ; O. Wichmann ; T. Mertens ; H. Hengel | [Concepts, effectiveness, and perspectives of pandemic and seasonal influenza vaccines]. |
| 000229 (2012) |
Mathieu Peeters [Belgique] ; Stefan Regner ; Tejaswini Vaman ; Jeanne-Marie Devaster ; Lars Rombo | Safety and immunogenicity of an AS03-adjuvanted A(H1N1)pmd09 vaccine administered simultaneously or sequentially with a seasonal trivalent vaccine in adults 61 years or older: data from two multicentre randomised trials. |
| 000244 (2012) |
Jp Cramer [Allemagne] ; T. Mac ; B. Hogan ; S. Stauga ; S. Eberhardt ; O. Wichmann ; T. Mertens ; Gd Burchard | Influenza A(H1N1)pdm09 antibodies after pandemic and trivalent seasonal influenza vaccination as well as natural infection in November 2010 in Hamburg, Germany. |
| 000256 (2012) |
Patricia R. Blank [Suisse] ; Genevieve Bonnelye ; Aurore Ducastel ; Thomas D. Szucs | Attitudes of the general public and general practitioners in five countries towards pandemic and seasonal influenza vaccines during season 2009/2010. |
| 000270 (2011) |
R. Allwinn [Allemagne] ; H W Doerr | [Comparison of seasonal influenza vaccines: composition and properties]. |
| 000292 (2011) |
J. Garcia-Sicilia [Espagne] ; P. Gillard ; A. Carmona ; J C Tejedor ; J. Aristegui ; J M Merino ; U. Behre ; A. Caplanusi ; T. Vaman ; I. Dieussaert | Immunogenicity and safety of AS03-adjuvanted H1N1 pandemic vaccines in children and adolescents. |
| 000311 (2010) |
J. Löwer [Allemagne] | [Pandemic influenza vaccines. How should they be designed?]. |
| 000448 (2007) |
J. Bürger [Allemagne] | [Development of vaccines against the next pandemic influenza virus]. |
| 000500 (2005) |
| Establishment of vaccination clinics; user fees for investigational new drug (IND) influenza vaccine services and vaccines. Interim final rule and request for comments. |
| 000551 (2001) |
W. Jilg [Allemagne] | [Adults tired of vaccines. Ask your patients about vaccine protection!]. |
